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Background: Compared with open esophagectomy (OE), minimally invasive esophagectomy (MIE) proves to have
clear benefits in reducing the risk of pulmonary complications for patients with resectable esophageal cancer. The
objectives of our study were to explore the superiority of MIE in reducing the occurrence of anastomotic leakages
(ALs) when compared to OE.
Methods: A systematic review and meta-analysis was performed to assess the superiority of MIE on the occurrence
of ALs over OE, by searching many sources (through December, 2014) such as Medline, Embase, Wiley Online
Library, and Cochrane Library. Fixed-effects model was used to calculate summary odds ratios (ORs) to quantify
associations between OE and MIE groups. Cochran’s Q and I2 statistics were used to evaluate heterogeneity among
studies.
Results: Among a total of 43 studies involving 5537 patients included in the meta-analysis, 2527 (45.6 %) cases
underwent MIE and 3010 (54.4 %) cases underwent OE. Compared to patients undergoing OE, patients undergoing
MIE did not have statistical significance in reduced occurrence of ALs (OR = 0.97, 95 % CI = 0.80–1.17). Insignificant
reduced occurrence of ALs was not associated with anastomotic location (OR = 0.90, 95 % CI = 0.71–1.13) or
anastomotic procedure (OR = 1.02, 95 % CI = 0.79–1.30).
Conclusions: More proofs are needed to clarify the strengths or weaknesses of MIE in preventing anastomotic
leakages after esophagectomy for cancer. A largely randomized, controlled trial should be undertaken to resolve
this contentious issue urgently.
Keywords: Minimally invasive esophagectomy, Open esophagectomy, Anastomotic leakagesBackground
Esophagectomy is a primary curative modality for local-
ized esophageal cancer. Esophagogastric anastomotic
leakage (AL) is a devastating complication of esopha-
geal resection and is associated with serious patient
morbidity and mortality [1–3]. The reported incidence
of ALs accounts for 40 % of postoperative fatalities after
esophagectomy, with the frequency ranged from 4 to
17 % [2, 4, 5]. Although the etiology of ALs is* Correspondence: chinahjj@163.com; renyyyyy@126.com
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article, unless otherwise stated.multifactorial, anastomotic technical errors and occult
ischemia of the mobilized gastric fundus are the two
major causes [1, 6]. Thus, choosing what surgical tech-
nique is supposed to play a major role. For example,
esophagogastric anastomoses after esophagectomy can
be performed in the neck or chest, by a hand-sewn
method or by using a mechanical stapling device [7, 8].
Minimally invasive esophagectomy (MIE), which was
first described in the 1990s [9–11], was attributed to the
superiority on a reduced risk of postoperative outcomes
without compromising oncological outcomes, avoiding
thoracotomy and laparotomy [12–17]. Therefore, theor-
etically, the procedure of MIE may have a significantis distributed under the terms of the Creative Commons Attribution 4.0
ns.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
give appropriate credit to the original author(s) and the source, provide a
indicate if changes were made. The Creative Commons Public Domain
.org/publicdomain/zero/1.0/) applies to the data made available in this
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tion of long laparoscopic and thoracoscopic instruments.
Nevertheless, after scrutinizing pertinent original re-
search articles and randomized controlled trials, we
found that this theoretical assumption has never been
subjected to empirical verification. The main reason for
this might be that previous studies focused too much on
efficacy and safety rather than surgical techniques.
Therefore, at least two critical questions are of consid-
erable interest and remain unanswered in esophageal
surgery: (i) whether MIE has superiority in reducing the
occurrence of ALs when compared to open esophagec-
tomy (OE) and (ii) whether the anastomotic methods or
sites of MIE have effect on prevention of ALs. For this,
we conducted the present systematic review and meta-
analysis to comprehensively explore the relation between
ALs and MIE, as well as ALs and the concomitant anas-
tomotic methods or sites, aiming to provide meaningful
clues for future research and current clinical practice.
Methods
Literature search
Two independent observers searched the following data-
bases in Medline, Embase, Wiley Online Library, and
other sources such as the Cochrane Library from incep-
tion to December 15, 2014. The databases were searched
using the terms minimally invasive esophagectomy,
esophageal cancer, esophageal carcinoma, and open
esophagectomy. This report complies with the preferred
reporting items for systematic reviews and meta-analyses
(PRISMA) [18].
Study selection
Studies were selected for inclusion if they met the
following criteria: (i) comparing MIE with OE, (ii) pub-
lished in English or Chinese, (iii) randomized or non-
randomized controlled study with parallel controls, and
(iv) gray literatures such as conference proceedings,
reports, and other peer-reviewed research.
The following studies were excluded: (i) interest was
not reported or it was impossible to calculate the out-
comes from the published results, (ii) not mentioning a
distinct group of patients or comparing the outcomes of
interest, and (iii) review articles, letters, comments, case
reports, and unpublished articles (abstracts only).
Quality assessment and data collection
The methodological quality of the included studies was
independently assessed by two observers using the meth-
odological index for non-randomized studies (MINORS)
instrument, a quality assessment tool specifically devel-
oped for systematic reviews of non-randomized control
studies [19]. The total quality score ranges from 0 (low
quality) to 24 (high quality). The disagreements betweenthe two observers were resolved by discussion with the
corresponding author via e-mail or personal interview.
The information, extracted from each publication in
the form of a table, included the following: authors, the
nation of origin, the year of publication, the number and
ages of the patients, etc. All eligible studies were
retrieved and evaluated by two independent reviewers.
Disagreements on inclusion were discussed with the
guidance of the corresponding author via e-mail, if
necessary.
Outcomes definition
The definition of minimally invasive esophagectomy
(MIE) is totally MIE, not including thoracoscopic/lapar-
otomy assisted esophagectomy, or hybrid MIE. Anasto-
motic leakages, leak, and fistula uniformly referred to
ALs.
Statistical analysis
The primary outcome measure was ALs, as it was con-
sidered an important outcome indicator in esophageal
surgery and had been used to compare outcomes among
different medical institutions. Secondary outcome in-
cluded the association of ALs and anastomotic sites or
methods for patients under MIE.
After appropriate conversion, data from the various
studies were combined using fixed-effects meta-analyses.
Forest plots were provided with pooled odds ratios
(ORs) and corresponding 95 % confidence intervals
(CIs). Begg’s funnel plot was used to provide diagnosis
of the potential publication bias [20]. Cochran’s chi-
square-based Q statistic test was performed in order to
assess possible heterogeneity between the individual
studies and thus to ensure that each group of the studies
was suitable for meta-analysis [21].Thresholds for inter-
pretation of heterogeneity were adopted as outlined in
the Cochrane Handbook: 0 to 40 %-low, 30 to 60 %-
moderate, 50 to 90 %-possible substantial, and 75 to
100 %-considerable heterogeneity. If the heterogeneity
was high [22] (I2 > 50 % or P < 0.10), a sensitivity analysis
would be performed using the “metaninf” Stata com-
mand. If the heterogeneity was deemed to be consider-
able, we would not pool the results and provide a
narrative assessment instead [23].All statistical processes
were done in Stata version 12.0 (Stata Corp LP, College
Station, TX, USA) software.
Results
Selected studies and methodological quality
Figure 1 shows a flow diagram of our search and selec-
tion process. Forty-four studies were selected from the
57 studies, with the reason that 13 studies did not com-
pare the outcomes of ALs. The evaluation results of the
methodological quality of the studies are shown in
Fig. 1 Flow diagram of the search and selection method
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ranged from 16 to 20 (Table 1). Randomized controlled
design was done in only one study [13].Characteristics of studies
The selected trials included a total of 43 studies and 5537
patients (Table 1). Among the included 43 studies, 19 were
retrospective studies [15, 24–41], 13 were prospective ones
[14, 42–53], and only 1 was randomized controlled trial
(RCT) [13]. Ten studies were done in Japan [25, 28, 29, 35, 43,
44, 50, 52, 54, 55], 9 in USA [14, 24, 27, 33, 41, 46, 51, 56, 57],
7 in China [31, 36, 38–40, 58, 59], 5 in the UK
[47, 49, 53, 60, 61], 3 in Netherlands [15, 34, 62], 3 in
Australia [42, 48, 63], 2 in Italy [45, 64], and the
remaining were conducted in Germany [30], Chile [26],
Belgium [32], and Finland [37].Type of surgery
Data for ALs were available for 43 studies totaling 5537
patients, of whom 2527 (45.6 %) patients underwent
MIE and 3010 (54.4 %) underwent OE, with an overall
ALs rate of 9.2 % (509/5537). The pooled OR of 0.97
(95 % CI = 0.80–1.17), as shown in Fig. 2, indicated no
significant reduction in the risk of ALs after MIE when
compared with OE, with no heterogeneity among results
from different studies (I2 = 0.0 %, P = 0.564).Anastomotic location of MIE
The analysis on anastomotic location of MIE on ALs status
was based on 34 trials or 4005 participants. An insignifi-
cant effect of the anastomotic location of MIE in ALs sta-
tus (OR = 0.90, 95 % CI = 0.71–1.13) was showed in Fig. 3,
with no statistical heterogeneity (I2 = 0.00, P = 0.771).
Twenty-eight studies, including a total of 3078 pa-
tients, had cervical anastomosis as anastomotic location
for MIE, with an overall rate of 9.0 % (278/3078). The
summary OR 0.84, as shown in Fig. 3, indicated that no
significant reduction of 14 cases per 1000 individuals
treated with MIE (95 % CI = 0.65–1.09) when compared
with OE, with no heterogeneity among results from
different studies (I2 = 0.0 %, P = 0.791).
The remaining 6 studies totaling 927 patients went
through thoracic anastomosis as anastomotic location for
MIE, with an overall ALs rate of 6.6 % (61/927). However,
fix-effects pooled analysis (OR = 1.14, 95 % CI = 0.69–
1.70) suggested that the incidence of ALs was not signifi-
cantly higher when compared with OE (33/449, 7.3 vs.
5.8 %, 28/478), with no heterogeneity among results from
different studies (I2 = 6.1 %, P = 0.377), as shown in Fig. 3.
Anastomotic procedure of MIE
The analysis on anastomotic procedure of MIE on ALs sta-
tus was based on 27 trials totaling in 3478 participants. No
statistical significance effect of anastomotic procedure of
Table 1 Characteristics and demographics of included studies
Study Year Country Design Cases ALs MINORS Adeno. % Anastomosis
MIE OE MIE OE Location Procedures
Smithers BM [42] 2007 Australia P 23 114 1 10 20 70.6 Cervical Hand-sewn
Kunisaki C [43] 2004 Japan P 15 30 2 1 16 NA Intrathoracic Stapler
Law S [58] 1997 China NA 18 63 0 2 16 NA Cervical Hand-sewn
Nguyen NT [24] 2000 USA R 18 36 2 4 16 NA Cervical Stapler and hand-sewn
Kubo N [25] 2014 Japan R 93 74 6 7 16 NA Cervical Unknown
Osugi H [44] 2003 Japan P 72 77 1 2 20 0 Cervical Unknown
Van den Broek WT [62] 2004 Netherlands NA 19 14 2 3 19 71.1 Cervical Hand-sewn
Braghetto I [26] 2005 Chile R 47 60 3 10 20 NA Cervical Hand-sewn
Benzoni E [45] 2006 Italy P 9 13 1 1 20 23.8 Cervical Hand-sewn
Fabian T [27] 2006 USA R 51 24 3 3 20 69.2 Cervical and intrathoracic Unknown
Shiraishi T [28] 2006 Japan R 78 37 9 9 16 NA Cervical Unknown
Bresadola V [64] 2007 Italy NA 22 43 1 2 16 NA Cervical Hand-sewn
Perry KA [46] 2009 USA P 21 21 4 6 16 45.2 Cervical Unknown
Parameswaran R [60] 2009 UK NA 50 30 4 1 19 82.5 Cervical Stapler
Kitagawa H [54] 2009 Japan NA 16 10 1 2 20 NA Cervical Hand-sewn
Zingg U [63] 2009 Australia NA 56 98 11 11 20 72.1 Cervical Hand-sewn
Saha AK [61] 2009 UK NA 16 28 2 3 19 16+ Cervical Stapler and hand-sewn
Hamouda AH [47] 2010 UK P 24 51 3 0 16 80 Intrathoracic Hand-sewn
Wang H [59] 2010 China NA 27 29 5 4 16 5.3 Cervical Unknown
Schoppmann SF [48] 2010 Australia P 31 31 1 8 20 46.8 Cervical Hand-sewn
Pham TH [14] 2010 USA P 44 46 4 5 16 74.4 Cervical and intrathoracic Stapler
Safranek PM [49] 2010 UK P 41 46 7 1 16 NA Cervical Stapler and hand-sewn
Tsujimoto H [29] 2010 Japan R 20 37 1 5 16 NA Cervical and intrathoracic Stapler and hand-sewn
Schröder W [30] 2010 Germany R 238 181 18 17 16 60.1 Intrathoracic Stapler
Berger AC [56] 2011 USA NA 65 53 9 6 16 79.7 Cervical Stapler
Yamasaki M [57] 2011 USA NA 109 107 6 4 16 79.7 Cervical Stapler
Gao Y [31] 2011 China R 96 78 7 6 16 5.2 Cervical Hand-sewn
Lee JM [50] 2011 Japan P 30 64 2 18 20 5.1 Cervical Stapler and hand-sewn
Nafteux P [32] 2011 Belgium R 65 101 5 10 16 75.3 Cervical Unknown
Sundaram A [33] 2012 USA R 47 57 4 4 20 78.8 Cervical Unknown
Sihag S [51] 2012 USA P 38 76 0 2 16 85.1 Intrathoracic Stapler
Maas KW [34] 2012 Netherlands R 50 50 4 3 20 69 Cervical Hand-sewn
Kinjo Y [52] 2012 Japan P 106 79 8 10 19 3.2 Cervical Unknown
Tsujimoto H [35] 2012 Japan R 22 27 7 3 Cervical and intrathoracic Stapler
Biere SS [15] 2013 Netherlands RCT 59 56 7 4 18 61.7 Cervical and intrathoracic Stapler
Noble F [53] 2013 UK P 53 53 5 2 19 NA Cervical and intrathoracic Stapler
Ichikawa H [55] 2013 Japan NA 153 162 14 27 20 66.7 Cervical and intrathoracic Hand-sewn
Mu J [36] 2014 China R 176 142 12 4 16 NA Cervical Stapler
Kauppi J [37] 2014 Finland R 74 79 7 6 18 NA Intrathoracic Hand-sewn
Meng F [38] 2014 China R 94 89 6 7 18 3.2 Cervical Hand-sewn
Zhang J [39] 2014 China R 60 61 3 2 16 NA Intrathoracic Stapler
Li J [40] 2014 China R 89 318 19 45 20 2.2 Cervical and intrathoracic Stapler and hand-sewn
Javidfar J [41] 2012 USA R 92 165 5 7 18 91 Cervical Unknown
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Fig. 2 MIE and risk of anastomotic leakages (ALs)
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showed in Fig. 3, with no statistical heterogeneity (I2 = 0.00,
P = 0.539).
Fifteen studies including 1687 cases had hand-sewn
anastomosis as anastomotic procedure for MIE, with an
overall rate of 9.5 % (160/1687). However, as shown in
Fig. 4, the pooled OR was 0.80 (95 % CI = 0.57–1.11)
which indicated insignificant reduction of 18 cases per
1000 individuals treated with MIE (62/732, 8.5 vs.
10.3 %, 98/955), with no heterogeneity among results
from different studies (I2 = 0.1 %, P = 0.448).
Twelve studies and 1791 cases investigated stapler anas-
tomosis as anastomotic method for MIE, with an overall
ALs rate of 7.1 % (128/1791). The pooled OR was 1.36 (95 %
CI = 0.94–1.97), showing insignificantly absolute decrease of
24 patients per 1000 individuals treated with MIE, with no
heterogeneity (I2 = 0.0 %, P= 0.807), as shown in Fig. 4.
Publication bias and sensitivity analysis
We plotted Begg’s funnel plot (Fig. 5) to examine small
study effects. We also used Begg’s and Egger’s weightedregression method to calculate P values for bias. As shown
in Fig. 5 the shape of the funnel plots did not reveal any
evidence of obvious asymmetry. The P values of the Egger’s
test were 0.869, 0.578, and 0.417 for type of surgery, anasto-
motic location of MIE, and anastomotic procedure of MIE,
respectively, implying no existence of publication bias.
The influence of each study on the pooled ORs was
examined by repeating the meta-analysis while sequen-
tially omitting individual studies. Sensitivity analysis for
type of surgery, anastomotic location of MIE, and anas-
tomotic procedure of MIE indicated that no single study
influenced the pooled ORs qualitatively, suggesting that
the results of our meta-analysis are stable.
Discussion
In our systematic review and meta-analysis, data to
study the superiority of MIE on the occurrence of ALs
was assessed in 43 studies totaling 5537 patients. We
showed in a comprehensive systematic review that the
use of stapler anastomosis for MIE might be insignifi-
cantly associated with the occurrence of ALs when
Fig. 3 Anastomotic location of MIE and risk of anastomotic leakages (ALs)
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or procedures.
As we described previously, resection for carcinoma of
the esophagus with gastric transposition is currently con-
sidered as the standard surgical treatment for cure or palli-
ation of esophageal cancer patients. Stomach is used most
commonly for restoring gastrointestinal continuity through
esophagogastrostomy anastomosis [7, 8]. AL after esopha-
geal resection for cancer is supposed to be a severe compli-
cation, which contributes to considerable mortality and
poor healing quality. In our analysis, the occurrence of ALs
was 9.2 % (509/5537), which was consistent with the fre-
quency 4–17 % reported in the previous papers. The preven-
tion of ALs appears quite important in clinical research.
Anastomotic technical errors and occult ischemia of the mo-
bilized gastric fundus were regarded as the two major causes
in the etiology of ALs. In comparison with OE technique, we
also found the AL rate tended to reduce after cervical anas-
tomosis but increase after intrathoracic anastomosis. The re-
sult was inconsistent with the previous report that MIE was
associated with an increased incidence of AL due to the
traumatic handling of the gastric conduit and the pressuretransmitted through rigid laparoscopic instruments during
mobilization, which resulted in increased tissue ischemia
[65, 66]. The discrepancies could be attributed by the differ-
ences in the size and design of included studies.
The classical open approaches for esophageal resection
include resection with a left thoracotomy, a thoracoabdom-
inal resection approach and left neck, thoracoabdominal
resection approach, also named as Sweet esophagectomy,
Ivor Lewis esophagectomy, and McKeown-type esophagec-
tomy. We know that esophagogastric anastomoses after
esophagectomy can be performed in the neck for Sweet
and Ivor Lewis approaches or the chest for three-incision
approach [7, 8]. Moreover, whether the anastomosis should
be performed in the neck or thorax is still a highly contro-
versial issue in reconstruction after esophagectomy. Some
authors favor anastomoses in the neck despite an increased
incidence of leakage and damage to the recurrent laryngeal
nerve due to better tumor eradication and reduced mortal-
ity and morbidity associated with an anastomotic break-
down [67, 68]. Others favor thoracic anastomosis for a
lower but more ominous leakage rate due to less esophagi
removed but decreased margins [69]. Consequently,
Fig. 4 Anastomotic procedure of MIE and risk of anastomotic leakages (ALs)
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age rates in the construction of intrathoracic and cervical
esophagogastric anastomosis. In our analysis, we found the
frequency of AL occurred in 8.3 and 9.7 % participators in
MIE and OE groups, respectively, when performed with
cervical esophagogastric anastomosis. However, no signifi-
cant differences in the occurrence of ALs between the two
groups were found when performed with thoracic or cer-
vical esophagogastric anastomosis. Therefore, more proofs
were needed to clarify the strengths and weaknesses of each
anastomotic location.Fig. 5 Begg plot of included studiesWe know that esophagogastric anastomoses can be
performed via hand-sewn or stapled techniques by using
mechanical stapling devices. Mechanical stapled anasto-
motic techniques, which were first described in 1977
[70], were deemed to have advantages of reduced time
and likelihood of esophagogastric anastomotic failure,
owing to the relatively ischemic gastric conduit resulting
from staple distribution, staple closure, and the more
uniform anastomotic tension along the entirety of the
anastomosis [71]. Many reports showed that mechanical
stapled anastomoses can decrease the rate of leakage
Zhou et al. World Journal of Surgical Oncology  (2015) 13:269 Page 8 of 10after esophagogastrostomy [72, 73]. In our analysis, we
failed to demonstrate a statistically significant difference
in anastomotic leak rate after the comparison of MIE
and OE undergoing hand-sewn or stapled technique.
This consistent result further partly corroborates the
existing evidence that mechanical stapled anastomoses
can decrease the rate of leakage after esophagogastrost-
omy [72, 73]. The underlying reason may be the similar-
ity in the adequately exposed operative field and level of
ischemic gastric conduit. Nevertheless, our results indi-
cated a tendency that the application of MIE could re-
duce the rate of ALs by hand-sewn anastomoses but
increased the rate of ALs by stapled anastomoses. There-
fore, there is insufficient evidence to clarify the strengths
or weaknesses of MIE in preventing anastomotic leak-
ages after esophagectomy for cancer.
Our meta-analysis has some limitations that might affect
the interpretation of the results. First of all, among the
included studies, only one was a RCT. The remaining 43
studies included were case-control or cross-sectional stud-
ies, which were susceptible to recall and selection biases.
Therefore, to some degree, the studies included could not
provide better evidence for potential treatment effects/
harms than RCT. There might have been some underre-
porting of weight and overreporting of height, which might
have led to an underestimation of the OR for this associ-
ation. Secondly, there existed differences in study designs,
demographics of participants, standardized protocols, histo-
pathological types, and the characteristics of the tumor
(poor tumor differentiation or advanced TNM stage). How-
ever, despite the use of appropriate meta-analytic tech-
niques, we are unable to account for these differences,
which may result in an overestimation or underestimation
of the effect of MIO. Thirdly, unmeasured or residual con-
founding was likely to be present, such as preoperative nu-
tritional status, intraoperative collateral tissue damage,
bleeding, worsening organ failure due to surgical trauma,
or difference of surgical techniques among the surgeons in
included studies. Finally, we have to admit that patients se-
lected for minimally invasive surgery are more likely to be
in early stages of cancer, with smaller tumors and less risk
of complications occurrence than patients in late stages.
Conclusions
Minimally invasive esophagectomy seems to have a sig-
nificant impact on the reduction in ALs risk due to the
introduction of long laparoscopic and thoracoscopic
instruments. A systematic review and meta-analysis can
help to confirm the superiority.
Currently, there is no evidence to clarify the strengths or
weaknesses of MIE in preventing anastomotic leakages after
esophagectomy for cancer. A largely randomized, con-
trolled trial should be undertaken to resolve this conten-
tious issue urgently.Competing interests
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